MEDCENTRAL BY CURASCRIPTSD Trademark

Trademark Overview

On Thursday, March 14, 2019, a trademark application was filed for MEDCENTRAL BY CURASCRIPTSD with the United States Patent and Trademark Office. The USPTO has given the MEDCENTRAL BY CURASCRIPTSD trademark a serial number of 88340130. The federal status of this trademark filing is REGISTERED as of Tuesday, May 11, 2021. This trademark is owned by Express Scripts Strategic Development, Inc.. The MEDCENTRAL BY CURASCRIPTSD trademark is filed in the Personal, Legal & Social Services category with the following description:

Consulting services, namely, conducting insurance benefit and coverage investigations and review for pharmaceutical and biotechnology companies
medcentral by curascriptsd

General Information

Serial Number88340130
Word MarkMEDCENTRAL BY CURASCRIPTSD
Filing DateThursday, March 14, 2019
Status700 - REGISTERED
Status DateTuesday, May 11, 2021
Registration Number6348708
Registration DateTuesday, May 11, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 25, 2020

Trademark Statements

Pseudo MarkMED CENTRAL BY CURASCRIPTSD; MEDICATION CENTRAL BY CURA SCRIPTS D
Goods and ServicesConsulting services, namely, conducting insurance benefit and coverage investigations and review for pharmaceutical and biotechnology companies

Classification Information

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 2, 2019
Primary Code045
First Use Anywhere DateMonday, December 31, 2018
First Use In Commerce DateMonday, December 31, 2018

Trademark Owner History

Party NameExpress Scripts Strategic Development, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63121
Party NameExpress Scripts Strategic Development, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63121
Party NameExpress Scripts Strategic Development, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63121

Trademark Events

Event DateEvent Description
Wednesday, May 15, 2019NON-FINAL ACTION WRITTEN
Monday, March 18, 2019NEW APPLICATION ENTERED
Tuesday, April 2, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 9, 2019ASSIGNED TO EXAMINER
Wednesday, May 15, 2019NON-FINAL ACTION E-MAILED
Wednesday, May 15, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 4, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 4, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 15, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 15, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 15, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 8, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 6, 2019FINAL REFUSAL WRITTEN
Friday, December 6, 2019FINAL REFUSAL E-MAILED
Friday, December 6, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, January 7, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, January 7, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 23, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 5, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 28, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, February 25, 2020PUBLISHED FOR OPPOSITION
Tuesday, February 25, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 13, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 28, 2020USE AMENDMENT FILED
Sunday, October 18, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 3, 2020NON-FINAL ACTION E-MAILED
Tuesday, November 3, 2020SU - NON-FINAL ACTION - WRITTEN
Tuesday, November 3, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 22, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 22, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 22, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 8, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, April 9, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, September 25, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 25, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 25, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 11, 2021REGISTERED-PRINCIPAL REGISTER

Related Keywords

curascriptsd medcentral review investigations pharmaceutical biotechnology companies coverage benefit services namely conducting